Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
5731316 | The American Journal of Surgery | 2017 | 5 Pages |
BackgroundA short course of potassium iodide (SSKI) has been traditionally used to prepare patients with Graves' disease for thyroidectomy. The rationale for this treatment has evolved over time; from control of hyperthyroidism to facilitating surgery by making the gland less friable and bloody.MethodsRandomized trial of preoperative SSKI vs no SSKI to test whether that is true.ResultsMean estimated blood loss in the SSKI group (62Â mL) was less than in the control group (162Â mL) as was the median estimated blood loss (50 vs 140Â mL). Mean (142 vs 162Â minutes) and median (138 vs 150Â minutes) operative times were also less in the SSKI arm. Subjective difficulty of operation was similar. Multivariable comparisons of groups with analysis of covariance showed the SSKI group suffered a mean blood loss 35% of the no treatment group (P = .036), the 9.2% decrease in Operating Room (OR) time between the SSKI group and the no treatment group was not statistically different (P = .464).ConclusionsSSKI given before operation in patients with Graves' disease reduces blood loss during thyroidectomy.